Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
Clinical trial NCT05222425 · UNKNOWN
Trial details
- NCT number
- NCT05222425
- Sponsor
- Biomad AS
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2022-10-15
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.